Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,825

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

·1997·The Lancet
DOI 10.1016/s0140-6736(96)11445-8
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(96)11445-8

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 33

  1. Brenner, 1982, Dietary protein intake and the progressive nature of kidney disease: the role of haemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis, N Engl J Med, 307, 652, 10.1056/NEJM198209093071104 · DOI · Paper page
  2. Hostetter, 1981, Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation, Am J Physiol, 241, F85
  3. Anderson, 1985, Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass, J Clin Invest, 76, 612, 10.1172/JCI112013 · DOI · Paper page
  4. Anderson, 1986, Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat, J Clin Invest, 77, 1993, 10.1172/JCI112528 · DOI · Paper page
  5. Mogensen, 1982, Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy, BMJ, 285, 685, 10.1136/bmj.285.6343.685 · DOI · Paper page
  6. Parving, 1983, Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy, Lancet, i, 1175, 10.1016/S0140-6736(83)92462-5 · DOI · Paper page
  7. Bjorck, 1992, Renal protective effect of enalapril in diabetic nephropathy, BMJ, 304, 339, 10.1136/bmj.304.6823.339 · DOI · Paper page
  8. Parving, 1988, Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy, BMJ, 297, 1086, 10.1136/bmj.297.6656.1086 · DOI · Paper page
  9. Kasiske, 1993, Effects of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis, Ann Intern Med, 118, 129, 10.7326/0003-4819-118-2-199301150-00009 · DOI · Paper page
  10. Weidmann, 1995, Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: an updated meta-analysis, Nephrol Dial Transplant, 10, 39
  11. Morelli, 1990, Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy, Diabetes, 39, 76, 10.2337/diacare.39.1.76 · DOI
  12. Remuzzi, 1993, Effect of low-dose enalapril on glomerular size selectivity in human diabetic nephropathy, J Nephrol, 6, 36
  13. Remuzzi, 1990, Angiotensin converting-enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat, J Clin Invest, 85, 541, 10.1172/JCI114470 · DOI · Paper page
  14. Remuzzi, 1995, Abnormal protein traffic through the glomerular barrier induces proximal tubular cell dysfunction and causes renal injury, Curr Opin Nephrol Hypertens, 4, 339, 10.1097/00041552-199507000-00009 · DOI
  15. Remuzzi, 1990, Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?, Kidney Int, 38, 384, 10.1038/ki.1990.217 · DOI · Paper page
  16. Bertani, 1986, Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy, Kidney Int, 30, 488, 10.1038/ki.1986.212 · DOI
  17. Hirschberg, 1996, Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions, J Clin Invest, 98, 116, 10.1172/JCI118755 · DOI
  18. Eddy, 1994, Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions, J Am Soc Nephrol, 5, 1273, 10.1681/ASN.V561273 · DOI
  19. Kamper, 1992, Effect of enalapril on the progression of chronic renal failure: a randomised controlled trial, Am J Hypertens, 5, 423, 10.1093/ajh/5.7.423 · DOI
  20. Ihle, 1996, Angiotensin converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double blind trial, Am J Kidney Dis, 27, 489, 10.1016/S0272-6386(96)90158-4 · DOI
  21. Hannedouche, 1994, Randomized controlled trial of enalapril and β-blockers in non-diabetic chronic renal failure, BMJ, 309, 833, 10.1136/bmj.309.6958.833 · DOI
  22. Zucchelli, 1992, Long-term comparison between captopril and nifedipine in the progression of chronic renal insufficiency, Kidney Int, 42, 452, 10.1038/ki.1992.309 · DOI · Paper page
  23. Maschio, 1996, Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency, N Engl J Med, 334, 939, 10.1056/NEJM199604113341502 · DOI · Paper page
  24. 1991, A long-term, randomized clinical trial to evaluate the effects of ramipril on the evolution of renal function in chronic nephropathies, J Nephrol, 3, 193
  25. Haybittle, 1971, Repeated assessments of results in clinical trials of cancer treatment, Br J Radiol, 44, 793, 10.1259/0007-1285-44-526-793 · DOI · Paper page
  26. Erman, 1991, Inhibition of angiotensin converting enzyme by ramipril in serum and tissue of man, J Hypertens, 9, 1057, 10.1097/00004872-199111000-00012 · DOI
  27. Gaspari, 1995, Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate in patients with normal or impaired renal function, J Am Soc Nephrol, 6, 1, 10.1681/ASN.V62257 · DOI · Paper page
  28. Rice, 1975, Improved biuret procedure for determination of urinary total proteins in clinical proteinuria, Clin Chem, 21, 398, 10.1093/clinchem/21.3.398 · DOI
  29. Parving, 1987, Effect of antihypertensive treatment on kidney function in diabetic nephropathy, BMJ, 294, 1443, 10.1136/bmj.294.6585.1443 · DOI · Paper page
  30. Rossing, 1994, Reduction in albuminuria predicts diminished progression in diabetic nephropathy, Kidney Int, 45, 145
  31. Apperloo, 1992, The initial antiproteinuric effect of antihypertensive treatment predicts the effect of treatment on long-term renal function outcome, J Am Soc Nephrol, 3, 279
  32. Petterson, 1995, Blood pressure control, proteinuria, and the progression of renal disease, Ann Intern Med, 123, 754, 10.7326/0003-4819-123-10-199511150-00003 · DOI · Paper page
  33. Remuzzi, 1991, Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy, Kidney Int, 39, 1267, 10.1038/ki.1991.160 · DOI

Cited by

See all 1,825

Metadata

Venue
The Lancet
Publisher
Elsevier BV
Published
1997-06
Volume
349
Issue
9069
Pages
1857-1863
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
DOI
10.1016/s0140-6736(96)11445-8
OpenAlex
W3156148333
Cited by
1,825
References
1
FWCI
59.94
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.